2015
DOI: 10.1016/j.bjhh.2014.07.024
|View full text |Cite
|
Sign up to set email alerts
|

A case of chronic myeloid leukemia with the m-bcr (p190) molecular rearrangement identified during treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 12 publications
(16 reference statements)
0
3
0
Order By: Relevance
“…To avoid the misdiagnosis of CML as CMML, it was proposed that the absence of relative monocytosis (a PB monocyte frequency of >8%; it was 8.5% in the present case) should be a criterion for the diagnosis of CML when the total number of leukocytes is higher than 20×10 9 /L ( 25 ). Ph-positive CML rarely expresses the p190 BCR-ABL transcript, which is often accompanied by prominent monocytosis and a hematological phenotype that is intermediate between those of CML and CMML ( 27 - 29 ). In our case, the conventional p210 BCR-ABL transcript, but not the p190 BCR-ABL transcript, was detected during an analysis based on the reverse transcription polymerase chain reaction.…”
Section: Discussionmentioning
confidence: 99%
“…To avoid the misdiagnosis of CML as CMML, it was proposed that the absence of relative monocytosis (a PB monocyte frequency of >8%; it was 8.5% in the present case) should be a criterion for the diagnosis of CML when the total number of leukocytes is higher than 20×10 9 /L ( 25 ). Ph-positive CML rarely expresses the p190 BCR-ABL transcript, which is often accompanied by prominent monocytosis and a hematological phenotype that is intermediate between those of CML and CMML ( 27 - 29 ). In our case, the conventional p210 BCR-ABL transcript, but not the p190 BCR-ABL transcript, was detected during an analysis based on the reverse transcription polymerase chain reaction.…”
Section: Discussionmentioning
confidence: 99%
“…This rare fusion transcript, also known as minor breakpoint cluster region (m-bcr), codes for a smaller (190kDa) oncoprotein with a unique clinical presentation between CML and chronic myelomonocytic leukemia (CMML). 4 …”
Section: Introductionmentioning
confidence: 99%
“…TO THE EDITOR: Minor BCR-ABL1 -positive chronic myeloid leukemia (CML) is a very rare subtype of CML, with only 1–2% of patients with CML exhibiting this fusion gene as a sole rearrangement [ 1 ]. Amongst the several reported cases in literature, and to the best of our knowledge, only one case has been reported in Korea so far [ 2 ].…”
mentioning
confidence: 99%